Procter & Gamble (NYSE:PG – Get Free Report) had its target price decreased by analysts at UBS Group from $196.00 to $189.00 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s target price would indicate a potential upside of 17.73% from the company’s previous close.
A number of other brokerages have also weighed in on PG. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. Wells Fargo & Company dropped their price objective on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. DA Davidson restated a “buy” rating and set a $209.00 target price on shares of Procter & Gamble in a report on Friday, December 27th. Finally, Piper Sandler assumed coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $180.05.
Get Our Latest Stock Report on PG
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period last year, the company earned $1.83 earnings per share. The company’s quarterly revenue was down .6% compared to the same quarter last year. Equities research analysts anticipate that Procter & Gamble will post 6.93 EPS for the current year.
Insider Transactions at Procter & Gamble
In other news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 75,439 shares of company stock worth $13,317,460. 0.18% of the stock is owned by insiders.
Institutional Investors Weigh In On Procter & Gamble
A number of institutional investors have recently added to or reduced their stakes in PG. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $28,000. RPg Family Wealth Advisory LLC acquired a new stake in Procter & Gamble during the third quarter worth $33,000. Quest Partners LLC bought a new stake in Procter & Gamble in the 2nd quarter valued at $36,000. Costello Asset Management INC raised its stake in shares of Procter & Gamble by 2,142.9% in the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company’s stock valued at $54,000 after buying an additional 300 shares in the last quarter. Finally, William B. Walkup & Associates Inc. acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $58,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- How to Invest in Biotech Stocks
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- What is the S&P 500 and How It is Distinct from Other Indexes
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.